Navigation Links
Emil Paganini, MD, Joins NxStage(R) as Critical Care Medical Advisor
Date:2/28/2008

LAWRENCE, Mass., Feb. 28 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), announced today that Emil Paganini, MD, formerly Section Head of Dialysis and Extracorporeal Therapy with the Cleveland Clinic Foundation, has joined the company as Critical Care Medical Advisor. Dr. Paganini will provide physician leadership for corporate clinical, scientific and educational initiatives to accelerate the company's efforts to transform renal therapies in the critical care environment with innovative yet simple solutions that benefit patients, caregivers and society.

"I am excited that this new role will enable me to continue to work with critical care clinicians, as part of a company that is making significant contributions to our critical care community," said Dr. Paganini. "NxStage is committed to optimizing CRRT's role in improving patient care and is leading the way with innovative support and education for critical care professionals. Jeff Burbank, President and CEO, explained, "We are very excited to add Dr. Paganini to our team. This represents a significant step forward in strengthening our scientific, clinical and educational initiatives. I believe that Dr. Paganini's exceptional track-record as an innovative and dynamic contributor will help us to accelerate our efforts to transform renal therapies in the critical care environment."

Dr. Paganini, MD, FACP, FRCP, was most recently Section Head of Dialysis and Extracorporeal Therapy at the Cleveland Clinic Foundation in Cleveland, Ohio. In addition, Dr. Paganini serves as Chairman of the Ohio Society of Nephrology and Past President of the Health Care Financing Administration Network 9/10. Dr. Paganini is a Coordinating Editor of the International Journal of Artificial Organs and serves on the editorial advisory boards of Seminars in Nephrology, Journal of Nephrology, Journal of Vascular Access, Contemporary Dialysis & Nephrology, and Nephrology News & Issues. He is a member with active participation of: 1) the American College of Physicians and serves on the Reimbursement Subcommittee, 2) the American Medical Association and serves as RUC Nephrology Representative, 3) Renal Physicians Association, and serves as AMA PEAC Advisor, 4) NephStrategies Inc. where he serves as President. He is also a member of the cardio-renal advisory board of the FDA. Dr. Paganini's work has appeared in numerous peer-reviewed journals including Kidney International, Nephrology, Dialysis and Transplant, Journal of the American Society of Nephrology, American Journal of Kidney Disease and Critical Care Medicine.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including, but not limited to, Dr. Paganini's ability to help us accelerate efforts to transform renal therapies in the critical care environment, and other factors that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended September 30, 2007. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward- looking statements, whether as a result of new information, future events or otherwise.

Contact:

Jane Hauser

Schwartz Communications

781-684-0770

nxstage@schwartz-pr.com


'/>"/>
SOURCE NxStage Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Camilo Villegas Joins Vijay Singh in Supporting Eagles for St. Jude Program
2. Nancy Frost Joins Lawson-Hawks as Employee Benefits Vice President
3. Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research
4. Microsoft Joins Forces with SAP America for Healthcare IT
5. Nationally Recognized Information Technology Veteran and Entrepreneur John Bamberger Joins gloStream, Inc. as Chief Channel Officer
6. John OConnell Joins Finesse Solutions as Vice-President of Sales and Business Development
7. Host Jennifer Love Hewitt Joins SBE, The Abbey and Los Angeles Magazine for The Envelope Please, Benefiting AIDS Project Los Angeles
8. True Orange Joins the True Lemon & True Lime Family
9. Secretary Norman Y. Mineta Joins Lung Cancer Alliance Board of Directors
10. Kelli Pedroia, Wife of Red Sox Dustin Pedroia, Joins Melanoma Foundation of New England to Warn About Tanning for the Prom
11. APA Joins With Give an Hour to Help Military Families
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... ... Image One USA veteran franchise owner Maria Bogacki is bringing ... Nashville that will benefit. , “I’ve enjoyed being a part of the Image One ... question that I would bring my business with me,” Bogacki said. “The entire Image ...
(Date:2/11/2016)... ... February 11, 2016 , ... The ... among the top five firms in the “2015/2016 Best in KLAS: Software and ... Staffing. KLAS is a research and insights firm on a global mission to ...
(Date:2/11/2016)... FL (PRWEB) , ... February 11, 2016 , ... ... and advocates will discuss how to improve care by making data on heart ... heart disease. The Summit on Transparency and Public Reporting of Pediatric and Congenital ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... Surgery, Dallas plastic surgeon , Dr. Rod J. Rohrich, and colleagues, examine ... Dr. Rohrich outlines recommendations for rhinoplasty surgeons when addressing this vital area. , ...
(Date:2/11/2016)... ... February 11, 2016 , ... veEDIS Clinical ... technology, with highly adaptable algorithms, has been updated to help Emergency Department physicians ... symptoms consistent with Zikas and a travel history to affected regions, or potential ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... 2016 Potrero Medical, Inc., the developer of the ... appointment of George M. Rapier, III , MD, to ... , WellMed is one of the nation,s largest physician ... members in Texas and ... his own internal medicine practice, he has been instrumental to ...
(Date:2/11/2016)... AAIPharma Services Corp./Cambridge Major Laboratories, Inc. ... development services for the pharmaceutical and biotechnology industries, ... in its Charleston, SC ... recent investments. Charleston ... with small-scale lyophilization. The site has invested in ...
(Date:2/11/2016)... SEOUL, South Korea , Feb. 11, 2016 Wearable posture tracker, ALEX , has ... project fully funded and just seven days left to go, ALEX is said to be delivered to ... http://photos.prnewswire.com/prnh/20160211/332248 ... ... ...
Breaking Medicine Technology: